Indivior (NASDAQ:INDV) Reaches New 52-Week High – Here’s What Happened

Indivior PLC (NASDAQ:INDVGet Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $15.58 and last traded at $16.09, with a volume of 2981689 shares trading hands. The stock had previously closed at $15.40.

Analyst Upgrades and Downgrades

INDV has been the subject of several research reports. Wall Street Zen raised shares of Indivior from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 21st. Craig Hallum lifted their price target on shares of Indivior from $15.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Indivior currently has a consensus rating of “Buy” and a consensus price target of $17.00.

Read Our Latest Stock Analysis on Indivior

Indivior Price Performance

The firm’s 50-day moving average is $12.79 and its 200-day moving average is $11.27.

Indivior (NASDAQ:INDVGet Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.19. The firm had revenue of $266.00 million for the quarter, compared to the consensus estimate of $240.13 million. Indivior had a negative net margin of 4.02% and a negative return on equity of 97.29%. Equities analysts forecast that Indivior PLC will post 1.22 earnings per share for the current year.

Hedge Funds Weigh In On Indivior

A number of hedge funds have recently bought and sold shares of the company. Deerfield Management Company L.P. Series C boosted its holdings in Indivior by 74.4% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 8,883,160 shares of the company’s stock worth $110,418,000 after acquiring an additional 3,790,518 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Indivior by 18.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,368,996 shares of the company’s stock worth $79,757,000 after acquiring an additional 1,299,425 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Indivior by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 4,631,221 shares of the company’s stock worth $43,765,000 after acquiring an additional 71,539 shares during the last quarter. Newtyn Management LLC boosted its holdings in Indivior by 17.4% during the 1st quarter. Newtyn Management LLC now owns 1,650,938 shares of the company’s stock worth $15,733,000 after acquiring an additional 244,407 shares during the last quarter. Finally, Millennium Management LLC boosted its holdings in Indivior by 36.9% during the 4th quarter. Millennium Management LLC now owns 1,233,006 shares of the company’s stock worth $15,326,000 after acquiring an additional 332,180 shares during the last quarter. 60.33% of the stock is owned by hedge funds and other institutional investors.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Further Reading

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.